J. Julian

发表

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial.

M. Gent, V. Marzinotto, P. Massicotte, 2003, Thrombosis research.

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.

M. Gent, V. Marzinotto, P. Massicotte, 2003, Thrombosis research.

Noninvasive Diagnosis of Deep Venous Thrombosis

M. Math, J. Julian, J. Ginsberg, 1998, Annals of Internal Medicine.

Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.

D. Lamping, S. Kahn, S. Solymoss, 2008, Annals of internal medicine.

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.

M. Gent, A. Turpie, S. Kahn, 2003, The New England journal of medicine.

Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care.

T. Whelan, D. Coyle, K. Pritchard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of hypofractionated radiation therapy for breast cancer.

Anthony Fyles, Jean-Philippe Pignol, Laval Grimard, 2010, The New England journal of medicine.

Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.

Do-Hoon Kim, T. Whelan, A. Nichol, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study

T. Whelan, L. Thabane, M. Levine, 2013, BMC Medical Research Methodology.

Radiotherapy for breast cancer.

T. Whelan, M. Levine, J. Julian, 2002, The New England journal of medicine.

Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.

M. Levine, J. Julian, S. Parpia, 2017, International Journal of Radiation Oncology, Biology, Physics.

A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia.

B. Leber, R. Kim, D. Leong, 2018, Blood advances.

Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.

D. Boreham, J. Julian, I. Dayes, 2009, International journal of radiation oncology, biology, physics.

A randomized trial comparing a combination of iridium implant and external beam radiation to external beam radiation alone for patients with locally advanced prostate cancer

M. Levine, J. Julian, H. Lukka, 2004 .

Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies

J. Julian, S. Bates, C. Kearon, 2016, Journal of thrombosis and haemostasis : JTH.

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis.

T. Whelan, A. Jadad, J. Julian, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer.

G. Pond, D. Coyle, A. Robidoux, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

C. Earle, M. Trudeau, M. Krzyzanowska, 2019, BMC Cancer.

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

Wilson Roa, T. Whelan, Y. Ung, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia.

M. Moore, M. Levine, E. Winquist, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selective d-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis

J. Douketis, M. O’Donnell, S. Kahn, 2013, Annals of Internal Medicine.

Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study.

J. Douketis, R. Taillefer, M. Levine, 2012, Thrombosis research.

Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative.

J. Julian, Jeffrey S. Ginsberg, C. Kearon, 1998, Annals of internal medicine.

A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study.

S. Kahn, M. Kovacs, W. Geerts, 2007 .

Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring for Acute Treatment of Venous Thromboembolism (VTE): Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH).

J. Douketis, J. Hirsh, M. Gent, 2004 .

Low-dose warfarin in rehabilitating stroke survivors.

W. Oczkowski, M. Gent, M. Cruickshank, 2002, Thrombosis research.

Cost effectiveness of a survivorship care plan for breast cancer survivors.

G. Pond, D. Coyle, K. Coyle, 2014, Journal of oncology practice.

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

J. Douketis, J. Denburg, J. Hirsh, 2003, The New England journal of medicine.

A prospective study to evaluate the role of 2-[18f] fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemo

K. Gulenchyn, J. Julian, N. Hodgson, 2010 .

Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study

F. D’Aragon, S. Kahn, M. Afilalo, 2022, BMJ.

F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer

K. Pritchard, M. Levine, K. Gulenchyn, 2015 .

Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial

Y. Ung, G. Darling, M. Levine, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis

S. Goldhaber, M. Jaff, D. Cohen, 2017, The New England journal of medicine.

Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability.

F. D’Aragon, A. Hirsch, M. Afilalo, 2019, The New England journal of medicine.

The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy

J. Douketis, P. Prandoni, S. Middeldorp, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS)

M. O’Donnell, J. Hirsh, S. Kahn, 2008, Thrombosis and Haemostasis.

Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial.

A. Gafni, C. Moulton, S. Gallinger, 2016, Journal of oncology practice.

Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.

M. Haider, C. Moulton, S. Gallinger, 2014, JAMA.

Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.

P. Liaw, L. Elit, M. Levine, 2012, Thrombosis research.

Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis

P. Wells, M. Levine, J. Julian, 1999, Annals of Internal Medicine.

Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study

J. Douketis, F. Spencer, S. Schulman, 2016, Journal of thrombosis and haemostasis : JTH.

Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism

J. Julian, S. Bates, C. Kearon, 2017, Thrombosis and Haemostasis.

Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

M. Gent, A. Turpie, S. Kahn, 2004 .

Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.

M. Levine, J. Julian, C. Webb, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Data collection in cancer clinical trials: Too much of a good thing?

G. Pond, J. Julian, E. O'Leary, 2013, Clinical trials.

Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times

L. Thabane, M. Levine, J. Julian, 2014, SpringerPlus.

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

M. Crowther, J. Julian, J. Ginsberg, 2004 .

Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial

J. Douketis, J. Hirsh, M. Gent, 2000, The Lancet.

Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study

J. Douketis, P. Prandoni, M. Kovacs, 2005, Journal of thrombosis and haemostasis : JTH.

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.

J. Douketis, J. Julian, Jeffrey S. Ginsberg, 2000, Thrombosis research.

Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up.

J. Julian, D. Arnold, I. Walker, 2006, Blood.

Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial.

C. Clase, A. Ingram, M. Crowther, 2002, Journal of the American Society of Nephrology : JASN.

Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement

G. Raskob, M. Gent, J. Heit, 2001, Circulation.

Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial

S. Goldhaber, M. Jaff, A. Salter, 2019, Vascular medicine.

Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial

T. Whelan, D. D'Souza, K. Pritchard, 2008, Breast Cancer Research and Treatment.

Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial

S. Kahn, S. Schulman, D. T. Nguyen, 2020, Seminars in Thrombosis and Hemostasis.

Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study

J. Douketis, S. Stevens, Vinay Shah, 2019, Journal of thrombosis and haemostasis : JTH.

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.

J. Douketis, S. Stevens, C. Kessler, 2015, Annals of internal medicine.

Treating clots in cancer: moving closer to an answer?

M. Levine, J. Julian, S. Parpia, 2014, The Lancet. Haematology.

Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism

J. Julian, C. Kearon, F. Couturaud, 2001, Thrombosis and Haemostasis.

Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with non-metastatic malignancy and venous thromboembolism (VTE)

M. Prins, M. Gent, M. Levine, 2003 .

A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE).

M. Prins, M. Gent, A. Kakkar, 2002 .

Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review.

M. O’Donnell, J. Hirsh, J. Julian, 2003, Archives of internal medicine.

Deep vein thrombosis

M. Kovacs, J. Julian, C. Kearon, 2005, The Lancet.

Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial

S. Goldhaber, S. Kahn, T. Murphy, 2019, Thrombosis and Haemostasis.

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

J. Douketis, S. Stevens, C. Kessler, 2018, Blood.

D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.

J. Douketis, S. Stevens, C. Kessler, 2016, Thrombosis research.

Dose-Response Study of Recombinant Factor VIIa / Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c 2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement

G. Raskob, H. Büller, M. Gent, 2001 .

d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism

S. Stevens, J. Julian, C. Kearon, 2015, Annals of Internal Medicine.

Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study Designer D-Dimer Deep vein thrombosis (4D) Study

F. D’Aragon, S. Kahn, M. Afilalo, 2022 .

Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis.

J. Douketis, S. Schulman, J. Julian, 2012 .

Risk of bleeding with vitamin K antagonists compared with low‐molecular‐weight heparin after orthopedic surgery: a rebuttal

M. O’Donnell, J. Julian, C. Kearon, 2005, Journal of thrombosis and haemostasis : JTH.

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.

M. Gent, A. Turpie, S. Kahn, 2008, Blood.

Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial

C. Earle, T. Vandenberg, M. Trudeau, 2021, BMJ.

OC-03 Randomized phase II trial of an oral factor Xa inhibitor in patients with metastatic cancer on chemotherapy

M. Levine, J. Julian, H. Liebman, 2010 .

A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer.

S. Solymoss, M. Levine, J. Julian, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central venous line-related thrombosis in children: association with central venous line location and insertion technique.

C. Male, M. Andrew, L. Mitchell, 2003, Blood.

An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).

M. Haider, C. Moulton, S. Gallinger, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Role of Aggressive Surgery in Advanced Epithelial Ovarian Cancer

M. Carey, L. Elit, M. Levine, 2001 .

Hip resurfacing: a complex challenge for device regulation

S. Schulman, J. Julian, S. Parpia, 2012 .

Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis

S. Goldhaber, S. Kahn, J. Julian, 2020 .

Predictors of recurrent thrombosis and anticoagulant-related bleeding in patients with cancer.

M. Prins, M. Levine, J. Julian, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of a VENOus-Return Assist Device (Venowave™) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.

M. O’Donnell, J. Hirsh, S. Kahn, 2006 .

Abstract GS4-03: RAPID: A randomized trial of accelerated partial breast irradiation using 3-dimensional conformal radiotherapy (3D-CRT)

T. Whelan, A. Nichol, W. Beckham, 2019, General Session Abstracts.

PRODIGE: A phase III randomized placebo-controlled trial of thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma

M. Malkin, W. Geerts, M. Levine, 2007 .

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials

Giancarlo Agnelli, Florent Boutitie, G. Raskob, 2011, BMJ : British Medical Journal.

Re: Is less more? Lessons in radiation schedules in breast cancer.

T. Whelan, M. Levine, J. Julian, 2003, Journal of the National Cancer Institute.

Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay.

C. Earle, M. Levine, N. Mittmann, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3D Conformal External Beam Radiation Therapy (3D CRT)

T. Whelan, I. Olivotto, P. Truong, 2013 .

Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer

T. Whelan, A. Fyles, J. Pignol, 2008 .

Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review

M. Gent, B. Eriksson, A. Turpie, 2004, Journal of thrombosis and haemostasis : JTH.

In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation.

J. Hirsh, J. Julian, J. Weitz, 2002, Thrombosis research.

The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial

T. Barbui, M. Levine, A. Falanga, 1998, Thrombosis and Haemostasis.

Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: reply

J. Julian, S. Bates, C. Kearon, 2016, Journal of thrombosis and haemostasis : JTH.

Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients.

V. Marzinotto, M. Andrew, L. Mitchell, 1999, Blood.

Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients.

M. Gent, V. Marzinotto, P. Massicotte, 2003, Thrombosis research.

Significant association with location of central venous line placement and risk of venous thrombosis in children

M. Gent, C. Male, P. Massicotte, 2005, Thrombosis and Haemostasis.

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.

C. Catton, P. Warde, G. Bauman, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial comparing two fractionation schedules for patients with localized prostate cancer.

W. J. Morris, P. Warde, M. Brundage, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reproducibility of the Histological Diagnosis of Cervical Dysplasia Among Pathologists From 4 Continents

L. Elit, J. Julian, K. Ceballos, 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Factors that predict thrombosis in relatives of patients with venous thromboembolism.

J. Douketis, S. Kahn, P. Wells, 2014, Blood.

Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.

J. Douketis, S. Kahn, P. Wells, 2009, Chest.

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.

M. Prins, M. Gent, M. Levine, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits.

J. Hirsh, M. Andrew, Anthony K. C. Chan, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

M. Prins, M. Gent, M. Kovacs, 2003, The New England journal of medicine.

Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.

Anthony Fyles, Laval Grimard, Mark Levine, 2002, Journal of the National Cancer Institute.

Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

S. Goldhaber, M. Jaff, D. Cohen, 2013, American heart journal.

J. Hirsh, M. Gent, J. Kelton, 1980, Blood.

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

A. Oxman, J. Julian, R. Grilli, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.

L. Thabane, M. Levine, J. Julian, 2011, Contemporary clinical trials.

Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor

J. Douketis, J. Hirsh, M. Gent, 2004, Journal of thrombosis and haemostasis : JTH.

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

M Gent, J. Hirsh, M. Gent, 1999, The New England journal of medicine.

Patients with severe sepsis vary markedly in their ability to generate activated protein C.

M. Loeb, C. Esmon, P. Liaw, 2004, Blood.

Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.

F. O'Malley, K. Pritchard, D. McCready, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

M. Malkin, R. Sawaya, W. Geerts, 2010, Journal of thrombosis and haemostasis : JTH.

HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab.

T. Whelan, K. Gelmon, I. Andrulis, 2008, Archives of pathology & laboratory medicine.

Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.

A. Eisen, Philippe Bédard, K. Pritchard, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Registries that show efficacy: good, but not good enough.

M. Levine, J. Julian, Mark N Levine, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group.

T. Whelan, M. Levine, J. Julian, 2000 .

Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer

T. Whelan, A. Fyles, M. Levine, 2002 .

Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.

P. Joshua, C. Male, M. Andrew, 2001, Blood.

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

J. Douketis, J. Hirsh, M. Gent, 2006, JAMA.

Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial

L. Hofmann, S. Goldhaber, M. Jaff, 2019, Circulation.

Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study.

C. Laskin, M. Crowther, J. Julian, 2000, Thrombosis research.

Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular- Weight Heparin for Acute Treatment of Venous Thromboembolism

J. Douketis, J. Hirsh, M. Gent, 2006 .

Implementation of a Web-Based Communication System for Primary Care Providers and Cancer Specialists

M. O’Brien, C. Liddy, A. Afkham, 2023, Current oncology.

The effects of radiation therapy on quality of life of women with breast carcinoma

P Kirkbride, T. Whelan, J. Julian, 2000, Cancer.

Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer.

T. Whelan, D. D'Souza, K. Pritchard, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis

S. Kahn, P. Wells, M. Rodger, 2005, Journal of thrombosis and haemostasis : JTH.

Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.

S. Goldhaber, M. Jaff, D. Cohen, 2019, Circulation. Cardiovascular quality and outcomes.

An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism

J. Douketis, P. Brill-Edwards, M. Gent, 2006, Annals of Internal Medicine.

Prevention and treatment of postphlebitic syndrome: results of a 3-part study.

M Gent, M. Gent, J. Julian, 2001, Archives of internal medicine.

Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios

M. Levine, S. Schulman, J. Julian, 2011, Annals of Internal Medicine.

Acute Toxicity and Quality of Life of Hypofractionated Radiotherapy for Breast Cancer.

T. Whelan, J. Arsenault, E. Rakovitch, 2015, International journal of radiation oncology, biology, physics.

Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate.

Qing Guo, Mark Levine, M. Levine, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis.

R. Taillefer, J. Julian, Jeffrey S. Ginsberg, 2003, Archives of internal medicine.

Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer.

Amiram Gafni, A. Gafni, T. Whelan, 2003, Journal of the National Cancer Institute.

Targeted Gene Sequencing Identifies Variants in the Protein C and Endothelial Protein C Receptor Genes in Patients With Unprovoked Venous Thromboembolism

D. Dwivedi, P. Liaw, D. Ginsburg, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Results of a multicenter randomized trial to evaluate a survivorship care plan for breast cancer survivors.

G. Pond, A. Robidoux, K. Pritchard, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus

J. Douketis, C. Laskin, M. Crowther, 1999, Thrombosis and Haemostasis.

Expectant management versus immediate treatment for low‐grade cervical intraepithelial neoplasia

L. Elit, M. Levine, J. Julian, 2011, Cancer.

A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial

G. Pond, D. Coyle, M. Levine, 2015, Journal of Cancer Survivorship.

A randomized trial of computer and pamphlet-based versions of the Decision Board (DB)

A. Gafni, T. Whelan, P. Ellis, 2007 .

The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study

J. Hirsh, M. Gent, W. Geerts, 1998, Thrombosis and Haemostasis.

A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care.

E Grunfeld, D Mirsky, D. Coyle, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial

J. Douketis, A. Turpie, S. Kahn, 2005, The Annals of pharmacotherapy.

Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC).

R. Gilbert, J. Waldron, L. Eapen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cross-border referral for early breast cancer: an analysis of radiation fractionation patterns

T. Whelan, M. Kuettel, J. Julian, 2006, Current oncology.

Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.

J. Kaufman, S. Goldhaber, M. Jaff, 2020, Journal of vascular surgery. Venous and lymphatic disorders.

Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial

G. Pond, M. O’Brien, C. Liddy, 2023, Journal of medical Internet research.

Reply to M. Jefford et al and C.T. Stricker et al

G. Pond, D. Coyle, E. Grunfeld, 2012 .

Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis.

T. Whelan, A. Nichol, A. Fyles, 2015, International journal of radiation oncology, biology, physics.

Cost-effectiveness of a survivorship care plan for breast cancer survivors.

G. Pond, D. Coyle, K. Coyle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.

Jim A. Julian, Zsolt Gabos, Timothy J. Whelan, 2017, Clinical lung cancer.

A prospective study evaluating 18F-Fluorodeoxyglucose (18FDG) positron emission tomography (PET) in the assessment of axillary nodal spread in women undergoing sentinel lymph node biopsy (SLNB) for breast cancer

K. Pritchard, D. McCready, M. Levine, 2008 .

An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.

Y. Ung, E. Yu, G. Darling, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer

S. Solymoss, J. Julian, H. Liebman, 2012, Journal of thrombosis and haemostasis : JTH.

357 Impact of Survivorship Care Plans (SCP) On Adherence to Guidelines, Health Service Measures, and Patient-reported Outcomes (PRO): Extended Results of a Multicenter Randomized Clinical Trial (RCT) with Breast Cancer Survivors

G. Pond, D. Coyle, M. Levine, 2012 .

A randomized controlled trial (RCT) of long-term follow-up for early stage breast cancer comparing family physician to specialist care: A report of secondary outcomes.

D. Coyle, K. Pritchard, E. Grunfeld, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study

K. Pritchard, D. McCready, M. Levine, 2012 .

Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy

M. O’Donnell, J. Julian, C. Kearon, 2010, Journal of thrombosis and haemostasis : JTH.

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.

J. Douketis, S. Stevens, C. Kessler, 2015, Annals of internal medicine.

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS)

M. O’Donnell, J. Hirsh, S. Kahn, 2008, Thrombosis and Haemostasis.

Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.

P. Liaw, L. Elit, M. Levine, 2012, Thrombosis research.

Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer

T. Whelan, L. Thabane, M. Levine, 2014, BMJ Open.